Abu Dhabi Receives First Shipment of Antibiotic Protecting Immunocompromised Individuals from COVID-19

Abu Dhabi has received its first shipment of a long-acting antibiotic aimed at protecting immunocompromised individuals against COVID-19, making it one of the first destinations globally to do so. This effort is part of the emirate's initiatives to safeguard all members of the community. AstraZeneca's AZD7442 protects at-risk patients and those with weak immune systems who have not been able to receive the COVID-19 vaccine and shields them from COVID-19 symptoms for up to 12 months after the first dose. It can be administered via intramuscular or intravenous injection.